TWIST BIOSCIENCE
Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development. At Twist Bioscience Corporation, they work in the service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for... all of them, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. Twist Bioscience was founded in 2013 and is headquartered in San Francisco, California.
TWIST BIOSCIENCE
Industry:
Biotechnology Chemical Health Care Life Science
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.twistbioscience.com
Total Employee:
501+
Status:
Active
Contact:
415-216-8966
Total Funding:
553.11 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Content Delivery Network LetsEncrypt Amazon Font Awesome HSTS
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_observer
Board_member
2013-07-01
Board_member
2013-01-01
Board_member
Board_member
2014-05-01
Board_member
2019-10-01
Board_member
2018-10-01
Board_member
2013-02-01
Current Employees Featured
Emily Leproust Chief Executive Officer @ Twist Bioscience
Chief Executive Officer
2013-04-01
Solange Glaize CFO @ Twist Bioscience
CFO
Robert Werner Chief Accounting Officer @ Twist Bioscience
Chief Accounting Officer
2020-05-01
Mark Daniels Chief Legal Officer @ Twist Bioscience
Chief Legal Officer
2016-08-01
Angela Bitting SVP, Corporate Affairs @ Twist Bioscience
SVP, Corporate Affairs
2020-11-01
Patrick Weiss COO @ Twist Bioscience
COO
Chet Gandhi Chief Information Officer @ Twist Bioscience
Chief Information Officer
2023-06-01
Jim Thorburn CFO @ Twist Bioscience
CFO
Adam Laponis Chief Financial Officer @ Twist Bioscience
Chief Financial Officer
2024-01-01
Garren Hilow Director, Business Development, In Vivo Discovery Services @ Twist Bioscience
Director, Business Development, In Vivo Discovery Services
2021-12-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-22 | Abveris | Abveris acquired by Twist Bioscience | 190 M USD |
| 2021-06-30 | iGenomX | iGenomX acquired by Twist Bioscience | 35 M USD |
| 2016-04-06 | Genome Compiler | Genome Compiler acquired by Twist Bioscience | N/A |
Investors List
Capital World Investors
Capital World Investors investment in Post-IPO Equity - Twist Bioscience
E Squared Capital Management
E Squared Capital Management investment in Venture Round - Twist Bioscience
Biomatics Capital Partners
Biomatics Capital Partners investment in Venture Round - Twist Bioscience
Bay City Capital
Bay City Capital investment in Venture Round - Twist Bioscience
Reinet Investments S.C.A.
Reinet Investments S.C.A. investment in Venture Round - Twist Bioscience
FIS
FIS investment in Venture Round - Twist Bioscience
Kangmei Pharmaceutical
Kangmei Pharmaceutical investment in Venture Round - Twist Bioscience
3W Partners
3W Partners investment in Venture Round - Twist Bioscience
NFT Investment
NFT Investment investment in Venture Round - Twist Bioscience
Ditch Plains Capital Management LP
Ditch Plains Capital Management LP investment in Venture Round - Twist Bioscience
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-07-17 | Sphere Fluidics | Twist Bioscience investment in Grant - Sphere Fluidics | 1.25 M USD |
Newest Events participated
Participated in HackingEDU
on 2015-10-23 as sponsor
Participated in HackingEDU
on 2015-05-23 as sponsor
Participated in SynBioBeta SF 2014
on 2014-11-13 as sponsor
Key Employee Changes
Official Site Inspections
http://www.twistbioscience.com Semrush global rank: 220.9 K Semrush visits lastest month: 193.34 K
- Host name: ec2-52-36-131-229.us-west-2.compute.amazonaws.com
- IP address: 52.36.131.229
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Twist Bioscience"
Twist Bioscience - Wikipedia
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. [2] …See details»
Twist Bioscience - Crunchbase Company Profile
Twist Bioscience reported positive financial results for the fiscal first and second quarters of 2024. The company launched several new products, including multiplexed gene fragments for high-throughput screening applications, …See details»
Twist Bioscience Information - RocketReach
Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production …See details»
Twist Bioscience - LinkedIn
Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production …See details»
Twist Bioscience Company Profile - Office Locations ... - Craft
Oct 29, 2024 Twist Bioscience has 5 employees across 8 locations and $312.97 m in annual revenue in FY 2024. See insights on Twist Bioscience including office locations, competitors, …See details»
Diversity is in our DNA | Meet the team - Twist Bioscience
The DNA-encoded nucleosome organization of a eukaryotic genome. Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Tillo D, Field Y, LeProust EM, Hughes TR, Lieb JD, Widom J, Segal E. Nature. 2009 458(7236) 362-6. …See details»
Twist Bioscience - Company Profile - Tracxn
5 days ago Twist Bioscience - Developer of a semiconductor-based DNA synthesis platform. Public Company. Raised a total funding of $321M over 11 rounds from 41 investors. Founded …See details»
Twist Bioscience | Investor Relations
23 hours ago The Investor Relations website contains information about Twist Bioscience's business for stockholders, potential investors, and financial analysts.See details»
Twist Bioscience Corporation (TWST) - Stock Analysis
Oct 31, 2018 Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product …See details»
Governance | Twist Bioscience
Additionally, Twist confirms the validity of each organization to which they sell and requires customers to agree not to resell synthetic DNA produced by Twist Bioscience unless they …See details»
Twist Bioscience - Overview, News & Similar companies - ZoomInfo
Aug 11, 2024 www.twistbioscience.com. Revenue $277.5 Million. Stock Symbol TWST. Industry Food & Beverages Food, Beverages & Tobacco Manufacturing . Most Recent Scoops. Aug 12 …See details»
Twist Bioscience Bolsters Executive Leadership Team
SAN FRANCISCO, Calif. – September 06, 2016 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced …See details»
Working At Twist Bioscience: Company Overview and Culture
Www.twistbioscience.com. Organization Type. Public. Social Media. Twist Bioscience is a healthcare company focusing on synthetic DNA tools, precision DNA synthesis, and …See details»
Twist Bioscience | Twist Bioscience Announces Promotions and …
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr. 21, 2022-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering …See details»
Corporate Responsibility | Twist Bioscience
Platform Reduces Reagent Use by 99.8%. We have miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip which is …See details»
Twist Bioscience | Twist Bioscience Achieves LEED Certification for ...
Sep 12, 2024 Wilsonville, OR facility LEED v4.1 Operations + Maintenance certified . SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep. 12, 2024-- Twist Bioscience Corporation …See details»
Twist Bioscience
The development of immunotherapeutics has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics …See details»
Twist Biopharma Solutions - Twist Bioscience
A New Era in Antibody Discovery. Modern therapeutic targets are getting more challenging and traditional, single modality platforms are no longer sufficient on their own.See details»
Twist Bioscience | Twist Bioscience Opens New Twist Boston …
Jul 6, 2022 New facility increases in vivo antibody discovery capacity. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul. 6, 2022-- Twist Bioscience Corporation …See details»
Quick Guide for the Trinity Workflow: Twist Fast Hybridization ...
Watch how Twist builds variant libraries for your perfect applicationSee details»